We take differentiated medical technologies from first regulatory submission through to clinical adoption and commercial scale — working inside theatre, ICU, cath lab and hospital executive forums, where adoption is actually decided.
Regulatory pathway management, territory mapping and clinical champion engagement.
PEC and VAC approval support, structured evaluations and in-theatre case coverage.
Capital tender navigation, consumables growth and long-range network expansion.
Ascensio Medical partners with global medtech OEMs, surgeons and hospital leaders to bring differentiated medical technologies into real-world clinical practice across Australia and New Zealand.
We operate where adoption is built — in theatre, ICU, cath lab and executive decision-making forums — embedding ourselves within clinical programs, procurement pathways and governance systems.
We activate. We implement. We support. We scale.
We do not operate outside the system. We work within it — clinically, operationally and commercially.
More than 20 years of leadership across medical devices, pharmaceuticals and biotechnology, including senior roles at Medtronic, Anteris Technologies and GE HealthCare. He has secured multi-million-dollar enterprise tenders and led statewide diagnostic deployments across more than 200 hospitals. MBA, University of Queensland.
A strategy and transformation leader specialising in digital infrastructure, governance frameworks and AI-enabled operating models. At Ascensio he leads the operational architecture behind structured market entry and sustained commercial performance across ANZ. MBA, University of Queensland.
A PhD-qualified perfusionist with more than 30 years of dedicated experience in cardiothoracic surgery, cardiopulmonary bypass and ECMO at The Prince Charles Hospital in Brisbane — one of Australia's leading cardiac centres. His expertise spans intraoperative blood conservation, extracorporeal membrane oxygenation and advanced mechanical circulatory support. He has authored more than 50 peer-reviewed publications in extracorporeal circulation and has held executive board roles within the Australian and New Zealand College of Perfusion.
Ascensio engages directly with internationally recognised clinical leaders across Australia and the United States in cardiothoracic surgery, cardiology, intensive care, perfusion, orthopaedics and respiratory medicine.
For OEM partners, this means market execution shaped by real clinical insight — not borrowed authority, but embedded expertise.